http://rdf.ncbi.nlm.nih.gov/pubchem/patent/SU-1055516-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_53ec44e654d8ab6084e651ad6d5856b0 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00 |
filingDate | 1982-07-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 1983-11-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5918c6028845ea81774e7240cae2f37f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_222403740706dee6b184dd7374cc71a8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e59a19a050500a4d30f3f786bdb1da75 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_be3456a6f5109aefa4044c05b8236e49 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_968861859acafc875548340d5c40a540 |
publicationDate | 1983-11-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | SU-1055516-A1 |
titleOfInvention | Method of treatment of rossolimo-milkerson-rosenthal's syndrome |
abstract | The special treatment of the Rossolimo Chilkerson-Rozental syndrome by administering protigiosan, B group vitamins and anthgistamines, characterized in that, with a chain of shortening the treatment time, the patient is also administered intra-. muscular heparin at a dose of 250O-3000 units. For injection, nicotinic acid and lidaza, orally phytin, glutamic acid, giperzine and pyridamole were administered locally twice a day, alternately by electrophoresis, oral phytin, glutamic acid, hypercinine and pyridamol, and locally, a heparin ointment and venor-Runton gel were applied to the skin every other day. |
priorityDate | 1982-07-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 30.